Oncopeptides appoints Holger Lembrer as Chief Financial Officer

/PRNewswire/ -- Oncopeptides AB (publ.) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...

Related Keywords

Norway ,Iceland ,Liechtenstein ,Stockholm ,Sweden ,United Kingdom ,Lichtenstein ,Monica Shaw ,Holger Lembrer ,Ernst Young ,Rolf Gulliksen ,Annika Muskantor ,Oncopeptides Holger Lembrer ,Leadership Team ,Assa Abloy ,European Union ,Global Head Of Corporate Communications ,Nasdaq Stockholm ,Chief Financial Officer ,Business Unit ,Investor Relations Officer ,Senior Auditor ,Global Head ,Corporate Communications ,Peptide Drug Candidate ,Marketing Authorization ,Small Cap ,Chief Financial ,Oncopeptides Ab ,